Mark A. Smith

5.2k citations

155 papers · 3.8k indexed · h-index 37

Impact in

Behavioral Neuroscience top 1%
- Stress Responses and Cortisol
Cellular and Molecular Neuroscience top 1%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Neuropeptides and Animal Physiology

Papers in ⓘ

Behavioral Neuroscience 20
- Stress Responses and Cortisol 20
Cellular and Molecular Neuroscience 75
- Neurotransmitter Receptor Influence on Behavior 55
- Neuropeptides and Animal Physiology 15
- Neuroscience and Neuropharmacology Research 14

Co-authors: Justin C. Strickland (18 shared papers)Wendy J. Lynch (6 shared papers)Jean M. Abel (5 shared papers)Elizabeth G. Pitts (5 shared papers)Drake Morgan (6 shared papers)Mitchell J. Picker (8 shared papers)Jordan C. Iordanou (7 shared papers)Karl T. Schmidt (10 shared papers)
Journals: Psychopharmacology (18 papers)Drug and Alcohol Dependence (13 papers)Behavioural Pharmacology (8 papers)Pharmacology Biochemistry and Behavior (8 papers)Journal of Pharmacology and Experimental Therapeutics (8 papers)
Partner nations: United States United Kingdom Sweden

In The Last Decade

Mark A. Smith

149 papers receiving 3.7k citations

Peers

Countries citing papers authored by Mark A. Smith

Since Specialization

Citations

This map shows the geographic impact of Mark A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Smith more than expected).

Fields of papers citing papers by Mark A. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Smith. The network helps show where Mark A. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Smith Line = papers co-authored together Mark A. Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Exercise as a novel treatment for drug addiction: A neurobiological and stage-dependent hypothesis Neuroscience & Biobehavioral Reviews ·Wendy J. Lynch, Alexis B. Peterson, Victoria Sánchez, Jean M. Abel, Mark A. Smith	2013	244
2	Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability Proceedings of the National Academy of Sciences ·Gary J. Grover, Karin Mellström, Ye Liu, Johan Malm, Yilin Li, Lars-Göran Bladh, Paul G. Sleph, Mark A. Smith, R.J. George, Björn Vennström, Kasim A. Mookhtiar, Ryan J. Horvath, Jessica Speelman, Donald Egan, John D. Baxter	2003	181
3	Aerobic exercise decreases the positive-reinforcing effects of cocaine Drug and Alcohol Dependence ·Mark A. Smith, Karl T. Schmidt, Jordan C. Iordanou, Martina L. Mustroph	2008	123
4	Exercise as a Potential Treatment for Drug Abuse: Evidence from Preclinical Studies Frontiers in Psychiatry ·Mark A. Smith, Wendy J. Lynch	2012	111
5	Pharmacologic Characterization of BMS-191095, a Mitochondrial KATP Opener with No Peripheral Vasodilator or Cardiac Action Potential Shortening Activity Journal of Pharmacology and Experimental Therapeutics ·G. J. Grover, A J D'Alonzo, Keith Garlid, Robert Bajgar, Nicholas J. Lodge, Paul G. Sleph, Raymond B. Darbenzio, Thomas Heß, Mark A. Smith, Petr Pauček, K. S. ATWAL	2001	85
6	Burns of the hand and upper limb—a review Burns ·Mark A. Smith, Andrew M. Munster, Robert Spence	1998	80
7	Effects of positive allosteric modulators of the GABA B receptor on cocaine self-administration in rats Psychopharmacology ·Mark A. Smith, David L. Yancey, Drake Morgan, Yu Liu, Wolfgang Froestl, David C. S. Roberts	2004	80
8	The effects of sex, estrous cycle, and social contact on cocaine and heroin self-administration in rats Psychopharmacology ·Ryan T. Lacy, Justin C. Strickland, Max Feinstein, Andrea M. Robinson, Mark A. Smith	2016	74
9	Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective The International Journal of Neuropsychopharmacology ·Erik H.F. Wong, Frank D. Yocca, Mark A. Smith, Chi‐Ming Lee	2010	74
10	Sensitivity to the effects of opioids in rats with free access to exercise wheels: �-opioid tolerance and physical dependence Psychopharmacology ·Mark A. Smith, David L. Yancey	2003	74
11	An Examination of the Interactions Between the Antinociceptive Effects of Morphine and Various [micro sign]-Opioids Anesthesia & Analgesia ·Drake Morgan, Charles D. Cook, Mark A. Smith, Mitchell J. Picker	1999	69
12	Peer influences on drug self-administration: Social facilitation and social inhibition of cocaine intake in male rats Psychopharmacology ·Mark A. Smith	2012	64
13	The effects of aerobic exercise on cocaine self-administration in male and female rats Psychopharmacology ·Mark A. Smith, Katherine L. Walker, Kathryn T. Cole, Kimberly C. Lang	2011	63
14	Investigations of High-Performance GaAs Solar Cells Grown on Ge–Si<tex>$_1-xhbox Ge_ x$</tex>–Si Substrates IEEE Transactions on Electron Devices ·C. Andre, John A. Carlin, John Boeckl, David M. Wilt, Mark A. Smith, Arthur J. Pitera, Minjoo Larry Lee, Eugene A. Fitzgerald, Steven A. Ringel	2005	61
15	A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression Psychopharmacology ·Erica M. Richards, Daniel C. Mathews, David A. Luckenbaugh, Dawn F. Ionescu, Rodrigo Machado‐Vieira, Mark J. Niciu, Wallace C. Duncan, Neal M. Nolan, Jose Franco‐Chaves, Thomas J. Hudzik, Carla Maciag, Shuang Li, A.J. Cross, Mark A. Smith, Carlos A. Zarate	2016	59
16	The effects of social contact on drug use: Behavioral mechanisms controlling drug intake. Experimental and Clinical Psychopharmacology ·Justin C. Strickland, Mark A. Smith	2013	58
17	The anxiolytic effects of resistance exercise Frontiers in Psychology ·Justin C. Strickland, Mark A. Smith	2014	56
18	Steady-State Pharmacokinetic, Safety, and Tolerability Profiles of Quetiapine, Norquetiapine, and Other Quetiapine Metabolites in Pediatric and Adult Patients with Psychotic Disorders Journal of Child and Adolescent Psychopharmacology ·Helen Winter, Willie Earley, J.E. Hamer-Maansson, Patty Davis, Mark A. Smith	2008	54
19	Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences. Journal of Pharmacology and Experimental Therapeutics ·Mitchell J. Picker, Jill Yarbrough, Christine E. Hughes, Mark A. Smith, Drake Morgan, L A Dykstra	1993	54
20	Contingent tolerance to the anticonvulsant effects of carbamazepine: Relationship to loss of endogenous adaptive mechanisms Brain Research Reviews ·Susan R.B. Weiss, Mike Clark, Jeffrey B. Rosen, Mark A. Smith, Robert M. Post	1995	53

About Mark A. Smith

Mark A. Smith is a scholar working on Behavioral Neuroscience, Cellular and Molecular Neuroscience, Social Psychology, Toxicology and Acoustics and Ultrasonics, having authored 155 papers that have together received 3.8k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (55 papers), Neuroendocrine regulation and behavior (22 papers), Stress Responses and Cortisol (20 papers), Pain Mechanisms and Treatments (17 papers), Receptor Mechanisms and Signaling (15 papers), Neuropeptides and Animal Physiology (15 papers), Neuroscience and Neuropharmacology Research (14 papers) and solar cell performance optimization (10 papers). The work is most often cited by research in Behavioral Neuroscience (446 citations), Cellular and Molecular Neuroscience (1.7k citations), Biological Psychiatry (118 citations), Applied Psychology (168 citations) and Toxicology (109 citations). Mark A. Smith has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Justin C. Strickland, Wendy J. Lynch, Jean M. Abel, Elizabeth G. Pitts, Drake Morgan, Mitchell J. Picker, Jordan C. Iordanou, Karl T. Schmidt, Ryan T. Lacy and Victoria Sánchez. Their work appears in journals such as Psychopharmacology, Drug and Alcohol Dependence, Behavioural Pharmacology, Pharmacology Biochemistry and Behavior and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact